anmelden
BX Swiss TOP 30 CHF
1.375,85
PKT
-15,97
PKT
-1,15
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.04.19 | Holcim Sell | UBS AG | |
| 11.04.19 | UBS buy | Deutsche Bank AG | |
| 11.04.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 11.04.19 | Roche buy | Goldman Sachs Group Inc. | |
| 10.04.19 | Givaudan Hold | Kepler Cheuvreux | |
| 10.04.19 | Alcon Neutral | UBS AG | |
| 10.04.19 | Novartis Underweight | Barclays Capital | |
| 10.04.19 | Nestlé overweight | Barclays Capital | |
| 10.04.19 | Novartis Underweight | Morgan Stanley | |
| 09.04.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 09.04.19 | UBS Neutral | JP Morgan Chase & Co. | |
| 09.04.19 | UBS overweight | JP Morgan Chase & Co. | |
| 09.04.19 | Givaudan Underperform | Bernstein Research | |
| 09.04.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 09.04.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 08.04.19 | Holcim buy | Deutsche Bank AG | |
| 08.04.19 | UBS buy | UBS AG | |
| 08.04.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 08.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.04.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 08.04.19 | Novartis Underweight | Barclays Capital | |
| 05.04.19 | Novartis Neutral | Credit Suisse Group | |
| 05.04.19 | UBS overweight | Morgan Stanley | |
| 05.04.19 | UBS Equal-Weight | Morgan Stanley | |
| 05.04.19 | Nestlé buy | Merrill Lynch & Co., Inc. | |
| 05.04.19 | Roche Hold | Deutsche Bank AG | |
| 05.04.19 | Novartis Hold | Deutsche Bank AG | |
| 04.04.19 | UBS buy | HSBC | |
| 04.04.19 | UBS buy | HSBC | |
| 03.04.19 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.04.19 | UBS Sector Perform | RBC Capital Markets | |
| 03.04.19 | UBS Sector Perform | RBC Capital Markets | |
| 03.04.19 | UBS Hold | Deutsche Bank AG | |
| 03.04.19 | Swiss Re overweight | Barclays Capital | |
| 03.04.19 | Zurich Insurance Equal weight | Barclays Capital | |
| 03.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 03.04.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 03.04.19 | Roche overweight | JP Morgan Chase & Co. | |
| 02.04.19 | Roche overweight | JP Morgan Chase & Co. | |
| 01.04.19 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. |